Jump to navigation

South Africa

Experts and activists demand more generous vaccine waivers

Over a year after India and South Africa called for emergency measures, WTO members have proposed a plan to waive patents on COVID-19 vaccines

Pressure is building on President Cyril Ramaphosa to reject a compromise proposal offered by the United States and the European Union for a temporary waiver of intellectual property (IP) on Covid-19 vaccines (AC Vol 63 No 7, Vaccine patent negotiators agree compromise formula).

Over 300 civic activists, trades unions, academics, and experts from across the world, including economics laureate Joseph Stiglitz wrote to India's Prime Minister Narendra Modi and Ramaphosa describing the leaked text on IP waivers 'inadequate' and 'a step backwards from an already untenable status quo.'

It is almost 18 months since India and South Africa asked the World Trade Organization to waive IP rights for medicines in the hope of aiding the 'prevention, containment and treatment of Covid-19'.

South African and Indian officials joined the talks that led to the compromise text prepared by the US and EU, but Ramaphosa and his ministers are yet to comment on its contents.

The leaked text proposes that the waiver would cover IP rights only on vaccines but not on treatments for Covid-19. It also states that, within six months of a final agreement, WTO members must decide on whether to extend it to include Covid-19 diagnostics and therapeutics as well. For the moment, there is no timetable for a full WTO meeting to approve or reject the plan. It would require consensus support.

It also suggested that the agreement would be restricted to five years. The waiver would apply to those WTO members that exported less than 10% of the world's vaccine doses in 2021; that provision would mean the EU, China, and the US could not benefit from the waiver.

The proposal, despite its modesty, is opposed by the pharmaceutical conglomerates. The European Federation of Pharmaceutical Industries and Associations (EFPIA) called 'on governments across Europe and around the world to urgently rethink discussions on a Covid vaccine waiver and instead focus on the real barriers to global vaccine equity'.



Related Articles

DISPATCHES

Vaccine patent negotiators agree compromise formula

World Trade Organization chief Okonjo-Iweala applauds progress but warns of struggle to convince all members states to back it

The lead team of negotiators has agreed a compromise on patents waiver over three to five years for Covid-19 vaccines which will require ratification by all WTO members....

READ FOR FREE

Clinging to the wreckage

The ANC leadership fired a shot across the President's bows. He is weaker than ever but no less determined to stay on

The African National Congress looked more deeply divided than ever as fault lines over the presidency of Jacob Zuma deepened early this week. A three-day meeting of the...


Secret oil deal

The emergence of Khulubuse Zuma, the nephew of South African President Jacob Zuma, as a leading player in Congo-Kinshasa’s oil industry has provoked curiosity and anger in almost...


For sale: one used war machine

Local and international buyers are circling the debt-crippled and state-owned Denel as it is forced to sell its assets to stay afloat

Denel, the remnant of the arms manufacturing and trading colossus Armscor that once propped up apartheid, is probably the least-known of South Africa's beleaguered state-owned enterprises.


Unsteady state of the nation

Zuma failed to inspire in his nationwide address yesterday. Many unknowns still surround the ANC’s promised 'radical economic transformation'

President Jacob Zuma's State of the Nation address to parliament was a disappointment to many. He did not expand on the African National Congress's plans to meet its...